Counsell N

ORCID: 0000-0002-0688-9192 · 1 paper in corpus · active 2025
2025
JAMA oncology ·doi:10.1001/jamaoncol.2024.6797

ImportanceAdvanced clear cell gynecological cancers (CCGCs) have a poor prognosis, with response rates to second-line chemotherapy less than 8%. Preliminary clinical activity with programmed cell death 1 protein (PD-1) inhibitors reported i…